ALSAF Stock Overview
A medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Safe Orthopaedics SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.054 |
| 52 Week High | €57.90 |
| 52 Week Low | €0.05 |
| Beta | 0.99 |
| 1 Month Change | -51.00% |
| 3 Month Change | -87.17% |
| 1 Year Change | -99.79% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Shareholder Returns
| ALSAF | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | -10.2% | 0.003% | -1.7% |
| 1Y | -99.8% | 23.6% | -4.8% |
Return vs Industry: ALSAF underperformed the French Medical Equipment industry which returned 23.6% over the past year.
Return vs Market: ALSAF underperformed the French Market which returned -4.8% over the past year.
Price Volatility
| ALSAF volatility | |
|---|---|
| ALSAF Average Weekly Movement | 32.2% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALSAF's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALSAF's weekly volatility has decreased from 64% to 32% over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 96 | Nicolas Papillon | www.safeorthopaedics.com |
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company’s products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Eragny-sur-Oise, France.
Safe Orthopaedics SA Fundamentals Summary
| ALSAF fundamental statistics | |
|---|---|
| Market cap | €1.85m |
| Earnings (TTM) | -€205.44m |
| Revenue (TTM) | €5.81m |
0.3x
P/S Ratio0.0x
P/E RatioIs ALSAF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALSAF income statement (TTM) | |
|---|---|
| Revenue | €5.81m |
| Cost of Revenue | €1.59m |
| Gross Profit | €4.22m |
| Other Expenses | €209.67m |
| Earnings | -€205.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.00 |
| Gross Margin | 72.70% |
| Net Profit Margin | -3,536.04% |
| Debt/Equity Ratio | -133.2% |
How did ALSAF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:45 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Safe Orthopaedics SA is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arnaud Riverain | GreenSome Finance |
| Martial Descoutures | Invest Securities |
| Daniel Anizon | Invest Securities |